ARTICLE | Distillery Therapeutics
Cancer
December 20, 2016 7:40 PM UTC
Mouse studies suggest inhibiting MLL1 could help treat AML and other leukemias. In primary mouse bone marrow cells expressing a leukemogenic human fusion oncogene, knockdown of MLL1 decreased colony f...
BCIQ Company Profiles
BCIQ Target Profiles
Myeloid-lymphoid or mixed-lineage leukemia protein (MLL1) (MLL) (HRX) (KMT2A)